Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Erratum: Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers.
Mol Ther Oncolytics. 2023 Oct 11;31:100735. doi: 10.1016/j.omto.2023.100735. eCollection 2023 Dec 19.
Mol Ther Oncolytics. 2023.
PMID: 37860015
Free PMC article.
Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers.
Chinsuwan T, Hirabayashi K, Mishima S, Hasegawa A, Tanaka M, Mochizuki H, Shimoi A, Murakami T, Yagyu S, Shimizu K, Nakazawa Y.
Chinsuwan T, et al.
Mol Ther Oncolytics. 2023 Sep 16;31:100728. doi: 10.1016/j.omto.2023.100728. eCollection 2023 Dec 19.
Mol Ther Oncolytics. 2023.
PMID: 37822488
Free PMC article.
Item in Clipboard
Cite
Cite